/
•
•
Detailed stories on technology startups, business and economic current affairs.
The spirits maker has landed itself in a cocktail of regulatory issues after it allegedly colluded with retailers to illegally boost sales of its products in the national capital

The spirits maker has landed itself in a cocktail of regulatory issues after it allegedly colluded with retailers to illegally boost sales of its products in the national capital

The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
A regulatory easing could see the billionaire’s conglomerate move from running airports to owning an airline—an idea he is warming up to, with multiple options open.
The Bengaluru-based contract manufacturer lands in legal hot water with the California-headquartered transformer startup over a trade secret dispute.
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
A regulatory easing could see the billionaire’s conglomerate move from running airports to owning an airline—an idea he is warming up to, with multiple options open.
The Bengaluru-based contract manufacturer lands in legal hot water with the California-headquartered transformer startup over a trade secret dispute.